z

Vaccination Schedules

National Childhood Immunisation Schedule (NCIS)1
(From birth to age 17 years, effective from 1 November 2020)

  Months Years
Vaccine Birth 2  4  6  12  15  18  2-4  5-9  10-11 12-13 13-14 15-17
Bacillus Calmette-GuĂ©rin (BCG) D1                        
Hepatitis B (HepB) D1 D2   D3                  
Diphtheria, Tetanus and acellular pertussis (paediatric)(DTaP)   D1 D2 D3     B1            
Tetanus, reduced diphtheria and acellular pertussis (Tdap)                   B2      
Inactivated poliovirus (IPV)   D1 D2 D3     B1     B2      
Haemophilus influenzae type b (Hib)   D1 D2 D3     B1            
Pneumococcal conjugate (PCV10 or PCV13)     D1 D2 B1                
Pneumococcal polysaccharide (PPSV23)               One of two doses for children and adolescents age 2-17 years with specific medical condition or indication.
Measles, mumps and rubella (MMR)         D1 D2              
Varicella (VAR)         D1 D2              
Human Papillomavirus (HPV2 or HPV4)                     D1
(Females)		 D2
(Females)		  
Influenza (INF)       Annual vaccination or per season for all children age 6 months to <5 years (6-59 months). Annual vaccination or per season for children and adolescents age 5-17 years with specific medical condition or indication.
 
Recommended ages and doses for all children
 
 
Recommended for persons with specific medical condition or indication

Footnotes:

D1, D2, D3: Dose 1, dose 2, dose 3
B1, B2: Booster 1, booster 2
10-11, 12-13, 13-14 years: Primary 5, Secondary 1, Secondary 2 (Tdap, IPV, HPV (for females) and MMR (as catch-up) vaccines are provided as part of Health Promotion Board's school-based vaccination programme)
Available vaccines are recommended in the National Children Immunisation Schedule (NCIS).1
These vaccinations are fully or partially subsidized for eligible Singaporean Citizens (SCs) and Permanent Residents (PRs) at polyclinics and/or CHAS GP clinics.2,3

National Adult Immunisation Schedule (NAIS)1
(For age 18 years and older)

Vaccine 18-26 years 27-64 years > 65 years
Influenza 1 dose annually or per season 1 dose annually or per season
Pneumococcal conjugate (PCV13) 1 dose 1 dose
Pneumococcal polysaccharide (PPSV23) 1 or 2 doses (depending on indication) 1 dose
Tetanus, reduced diphtheria and acellular pertussis (Tdap) 1 dose during each pregnancy
Human papillomavirus (HPV2 or HPV4) 3 doses
(Females)		    
Hepatitis B (HepB) 3 doses
Measles, mumps and rubella (MMR) 2 doses
Varicella (VAR) 2 doses
 
Recommended for adults who meet age requirement
 
 
Recommended for adults with specific medical condition or indication
 
 
Recommended for adults who have not been previously vaccinated, or lack evidence of past infection or immunity

Footnotes:

Available vaccines are recommended in the National Adult Immunisation Schedule (NAIS).1
Singaporean adults receive partial subsidies at polyclinics and/or CHAS GP clinics and MediSave can be used to cover the remaining co-payment.3,4
Under MediSave 500 & MediSave 700, eligible Singaporean can use up to $500 / $700 for approved vaccinations.5
Under the Outpatient Flexi-MediSave, patients above 60 can use up to $300 for approved vaccinations.5

References

  1. MOH. Nationally Recommended Vaccines. Available at: https://www.moh.gov.sg/resources-statistics/nationally-recommended-vaccines. Last accessed May 2023.
  2. MOH. Vaccination and Childhood Developmental Screening Subsidies. Available at: https://www.moh.gov.sg/healthcare-schemes-subsidies/vaccination-and-childhood-developmental-screening-subsidies. Last accessed May 2023.
  3. MOH. Fee Caps at CHAS GP clinics. Available at: https://www.moh.gov.sg/docs/librariesprovider5/default-document-library/annex-ccc11b38be28c4718bf104e5432281c74.pdf. Last accessed May 2023.
  4. CHAS. CHAS FAQs. Available at: https://www.chas.sg/faqs. Last accessed May 2023.
  5. MOH. Medisave. Available at: https://www.moh.gov.sg/healthcare-schemes-subsidies/medisave. Last accessed May 2023.

This is a disease awareness initiative by GSK for Singapore.

For further information, please consult your doctor.

© 2024 GSK group of companies or its licensor

All images used in this material are for illustration purposes only.

NP-SG-ABX-WCNT-230001
Date of Approval: Jan 2024

GSK.com

Contact Us
Top